Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 42.90M | $ 19.50M | $ 11.10M | $ 67.10M | $ 85.40M |
Total Assets | $ 503.60M | $ 549.20M | $ 546.00M | $ 615.70M | $ 584.70M |
Total Debt | $ 145.20M | $ 153.60M | $ 113.30M | $ 95.30M | $ 106.10M |
Net Debt | $ 102.30M | $ 134.10M | $ 102.20M | $ 28.20M | $ 20.70M |
Total Liabilities | $ 417.20M | $ 476.80M | $ 455.90M | $ 519.30M | $ 489.80M |
Stockholders Equity | $ 87.30M | $ 73.40M | $ 91.40M | $ 97.70M | $ 96.00M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |